The Pancreatic Tumor Microenvironment

Systems Biology of Stroma-Microbiome Interactions for Precision Therapy

Häftad, Engelska, 2027

AvGanji Purnachandra Nagaraju,Mundla Srilatha

2 209 kr

Kommande

The Pancreatic Tumor Microenvironment: Systems Biology of Stroma-Microbiome Interactions for Precision Therapy unites leading experts to integrate stromal biology and microbiome science into a single, translational roadmap for pancreatic cancer. It frames tumor progression and treatment resistance as emergent properties of an ecosystem, not isolated cells. The book surveys the composition and heterogeneity of the tumor microenvironment; cancer associated fibroblast plasticity; extracellular matrix and signaling dynamics; immune suppression; metabolic and hypoxic reprogramming; and gut/tumor associated microbiomes. Methodological chapters highlight single cell, spatial and multi omics approaches, experimental models, biomarkers, and clinical trial design, culminating in combination strategies and future directions. Readers gain a mechanistic, systems level synthesis that clarifies conflicting literature, prioritizes targets, and bridges basic, translational, and clinical domains-accelerating precision oncology and informing study design, patient stratification, and therapeutic combinations.

Integrates stromal, immune, mechanical, and microbiome mechanisms into an ecosystem framework that explains pancreatic tumor resistance and progression
Bridges basic science, cutting edge models (single cell, spatial, multi omics), and clinical trial design for actionable translation
Prioritizes therapeutic strategies for pancreatic cancer with clear biomarker and stratification guidance

Produktinformation

Utgivningsdatum2027-02-01
Mått191 x 235 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
Antal sidor220
FörlagElsevier Science
ISBN9780443517426

Tillhör följande kategorier

Biologi inom Naturvetenskap och teknik

Dr. Nagaraju obtained his MSc and his PhD, both in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. He received his DSc from Berhampur University in Berhampur, Odisha, India. Dr. Nagaraju’s research focuses on translational projects related to gastrointestinal malignancies. He has published over 100 research papers in highly reputed international journals and has presented more than 50 abstracts at various national and international conferences. Dr. Nagaraju is author and editor of several published books for Elsevier and Springer Nature. He serves as editorial board member of several internationally recognized academic journals. Dr. Nagaraju has received several international awards including FAACC. He also holds memberships with the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), The Science Advisory Board, The RNA Society, The American Association for Clinical Chemistry (AACC) and the American Association of Cancer Research (AACR). Dr. Mundla Srilatha earned her PhD in Biotechnology at the Sri Venkateswara University, Tirupati, India. Currently, she is working as an academic consultant (faculty) Sri Venkateswara University, India. She published several articles in reputed international journals. She also published four books and a few book chapters at the international level. She received several national awards, and she was honored with the prestigious national-level “Dr. Sarvepalli Radhakrishna Best Teacher Award. She serves as an editorial board member of several internationally recognized academic journals.

1. Unmet Needs and Clinical Difficulties in Pancreatic Cancer2. Composition, Heterogeneity, and Function of the Pancreatic Cancer Microenvironment3. The Development of Pancreatic Cancer Stromal Targeting: From Depletion to Reprogramming4. Functional Subtypes and Cancer Associated Fibroblast Plasticity in Pancreatic Cancer5. Signaling and Extracellular Matrix Remodelling in Pancreatic Cancer6. Immune Suppression and Stromal–Immune Crosstalk in Pancreatic Cancer7. Pancreatic Cancer Stroma Metabolic and Hypoxic Reprogramming8. The Microbiome Associated with the Gut and Tumor in the Development and Progression of Pancreatic Cancer9. Interactions between the Microbiome, Immune System, and Stroma in Pancreatic Cancer10. Modulating the Microbiome Therapeutically in Pancreatic Cancer11. Investigating Pancreatic Cancer Stroma and Microbiome Interactions through Experimental Models12. Pancreatic Cancer Research Using Single Cell, Spatial, and Multi Omics Methods13. Clinical Trial Design, Patient Stratification, and Biomarkers14. Combination Treatments for the Microbiome, Stroma, and Tumor Cells15. Conclusion and Prospects for Reprogramming the Pancreatic Cancer Microenvironment